Google
VOR — VOR BIOPHARMA INC (Healthcare >> Biotechnology)
VOR FAQ
What is VOR's P/E ratio?
VOR BIOPHARMA INC (VOR) currently trades at a P/E ratio of 0.42.
What is VOR's ROE?
VOR BIOPHARMA INC reports a Return on Equity (ROE) of 587.06%.
What is VOR's dividend yield?
VOR BIOPHARMA INC offers a dividend yield of 0.00%.
What is VOR's Deepscope Quality Score?
Deepscope rates VOR's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VOR?
Deepscope's AI Timing Score for VOR is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VOR belong to?
VOR BIOPHARMA INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 13.00
Price
-0.28
(-2.11%)
Day Change
|
|
|---|
VOR, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
54% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 13.00 |
| PBV / Sector |
-4.78 / 4.79
|
| Earning Per Share | -15.95 |
| PE / Sector |
0.42 / 17.89
GREAT
|
| PEG or PE/Growth / Sector |
0.02 / 0.56
GREAT
|
| Average 1M Daily Value |
11.00 M
GREAT
|
| Average 1W Daily Value |
9.99 M
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-11 09:54:49 |
| Symbol | VOR |
| Name | VOR BIOPHARMA INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 54.19 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 719.59 / 8,963.32 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 500 Boylston Street, Boston, MA, United States, 02116
Phone: 617 655 6580
Website: https://www.vorbio.com
Employees: 76
Sector: Healthcare >> Biotechnology
Description: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
